ABCL
Price
$3.80
Change
+$0.05 (+1.33%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
1.12B
40 days until earnings call
PRME
Price
$3.11
Change
+$0.04 (+1.30%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
358.43M
34 days until earnings call
Interact to see
Advertisement

ABCL vs PRME

Header iconABCL vs PRME Comparison
Open Charts ABCL vs PRMEBanner chart's image
AbCellera Biologics
Price$3.80
Change+$0.05 (+1.33%)
Volume$49.12K
Capitalization1.12B
Prime Medicine
Price$3.11
Change+$0.04 (+1.30%)
Volume$59.48K
Capitalization358.43M
ABCL vs PRME Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. PRME commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and PRME is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ABCL: $3.75 vs. PRME: $3.07)
Brand notoriety: ABCL and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 152% vs. PRME: 246%
Market capitalization -- ABCL: $1.12B vs. PRME: $358.43M
ABCL [@Biotechnology] is valued at $1.12B. PRME’s [@Biotechnology] market capitalization is $358.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while PRME’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • PRME’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than PRME.

Price Growth

ABCL (@Biotechnology) experienced а -1.32% price change this week, while PRME (@Biotechnology) price change was +26.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

PRME is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.12B) has a higher market cap than PRME($358M). ABCL YTD gains are higher at: 27.986 vs. PRME (5.137). PRME has higher annual earnings (EBITDA): -200M vs. ABCL (-211.2M). ABCL has more cash in the bank: 605M vs. PRME (144M). ABCL has less debt than PRME: ABCL (67.8M) vs PRME (121M). ABCL has higher revenues than PRME: ABCL (23.1M) vs PRME (3.85M).
ABCLPRMEABCL / PRME
Capitalization1.12B358M313%
EBITDA-211.2M-200M106%
Gain YTD27.9865.137545%
P/E RatioN/AN/A-
Revenue23.1M3.85M601%
Total Cash605M144M420%
Total Debt67.8M121M56%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLPRME
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 22 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VWAPY10.660.20
+1.91%
Volkswagen AG
TRLEF0.03N/A
+0.78%
Trillion Energy International Inc.
BTSBF17.54N/A
N/A
Betsson AB
IAFNF107.14-0.26
-0.24%
IA FINL CORP INC.
ENZN0.11N/A
-3.86%
Enzon Pharmaceuticals, Inc.